Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects

NCT02242149 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Diacerein
DRUG: Placebo

Sponsor

Universidade Federal do Rio de Janeiro

Collaborators

[object Object]